Recently, it has been recognized that the symptoms suffered by those with long-COVID
may be due to autonomic dysfunction or postural orthostatic tachycardia syndrome (POTS).
Previous works have identified the potential utility of plasma exchange for POTS and
other neurological conditions with associated antecedent viral onset.
1
,2
Here, we present the first report of a patient with improved cognitive and neurological
symptomology following plasma exchange in long-COVID-related POTS and autoimmune neurological
dysfunction.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Plasma exchange therapy in postural tachycardia syndrome: a novel long-term approach?.Am J Med. 2020; 133: e157-e159
- A pediatric case of severe pandysautonomia responsive to plasmapheresis.J Child Neurol. 2013; 28: 1716
- Inflammatory biomarkers in postural orthostatic tachycardia syndrome with elevated g-protein-coupled receptor autoantibodies.J Clin Med. 2021; 10: 623
- Functional autoantibodies against G-protein coupled receptors in patients with persistent post-COVID-19 symptoms.J Transl Autoimmun. 2021; 4100100
Article info
Publication history
Published online: February 21, 2023
Accepted:
January 24,
2023
Received:
December 4,
2022
Publication stage
In Press Journal Pre-ProofFootnotes
Funding: M-CS is supported by an Australian Government Research Training Program Scholarship. M-CS, CG and DHL are supported by research funding from Standing Up To POTS. CG is supported by a postdoctoral fellowship from the University of Adelaide. DHL is supported by a Mid-Career Fellowship from the Hospital Research Foundation.
Conflicts of Interest: DHL reports that the University of Adelaide has received on his behalf lecture and/or consulting fees from Abbott Medical, Biotronik, Medtronic and MicroPort CRM. M-CS, MH, JT, RW, CG report none.
Authorship: All authors had access to the data and a role in writing this manuscript.
Identification
Copyright
© 2023 Elsevier Inc. All rights reserved.
